Case report: Emerging BRCA mutation confers benefit from olaparib after chemotherapy intolerance in advanced triple‐negative breast cancer
Article in Clinical Case Reports (April 2024)
The most recent citing publications are shown below. View all 64 publications that cite this research output on Dimensions.
Apigenin and its nanoformulations for ameliorating normal tissue toxicity and enhancing tumor response to therapy: A mechanistic viewpoint
Article in Journal of Drug Delivery Science and Technology (February 2024)
Crocin enhances the sensitivity to paclitaxel in human breast cancer cells by reducing BIRC5 expression
Article in Chemical Biology & Drug Design (January 2024)